Our article Statistics and Ontology of Published Small Molecule Ring Systems has been published in Molecular Informatics, 2026; 45:e7002 Diversity […]
Author: Lutz Weber
New MolGenie branch in Leipzig
Starting March 1, 2026 we are starting a new branch office in Leipzig. We are glad to start new projects […]
New chemoinformatics publication
“Statistics and Ontology of Published Small Molecule Ring Systems” has recently been published. Diversity and properties of ring systems contained […]
Patent granted for E7 inhibitors
Our patent application “ISOQUINOLINE DERIVATIVES FOR USE AS ANTIVIRAL AND ANTITUMOUR AGENTS” (EP 4 322 949 B1) has been granted […]
ZeroPM
efforts to make our world more safe – participating in the EU project https://zeropm.eu/ on persistent and mobile toxic molecules…: […]
Cysteine Protease Inhibitors And Methods Of Use Thereof
We are pleased to report that the captioned application issued as U.S. Patent No. 12,077,605 as an electronic patent grant […]
How to extract chemical knowledge from images
our paper “Comparing software tools for optical chemical structure recognition” has been published in Royal Society journal Digital Discovery. See […]
Novel targeted E7 protein degraders
A new PCT patent application claiming new viral protein E7 degraders has been published as WO2022219157A1. The invention was made […]
Anixa-MolGenie compounds are more potent than the protease inhibitor in Pfizer’s PAXLOVID™ at inhibiting the main protease of SARS-CoV-2
SAN JOSE, Calif. and STUTTGART, Germany, Jan. 24, 2022 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused […]
Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant
Dec. 7, 2021 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious […]